Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013

International Journal of Infectious Diseases

Volumn 29, Issue , 2014, Pages 254-258

  Gao, Hai Nv ^a,b   Yao, Hang Ping ^a,b   Liang, Wei Feng ^a,b   Wu, Xiao Xin ^a,b   Wu, Hai Bo ^a,b   Wu, Nan Ping ^a,b   Yang, Shi Gui ^a,b   Zhang, Qiong ^a,b   Su, Kun Kai ^a,b   Guo, Jing ^a,b   Zheng, Shu Fa ^a,b   Zhu, Yi Xin ^a,b   Chen, Hong Lin ^b,c   Yuen, Kwok yung ^b,c   Li, Lan Juan ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drug sensitivity; H7N9; Human to human transmission; Influenza; Oseltamivir; Peramivir

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; LACTATE DEHYDROGENASE; OSELTAMIVIR; PERAMIVIR; ANTIVIRUS AGENT;

ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL SUSCEPTIBILITY; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHINA; CLINICAL FEATURE; HUMAN; IC50; INFLUENZA A; INFLUENZA A (H7N9); INFLUENZA A VIRUS (H7N9); MALE; MIDDLE AGED; PHYLOGENETIC TREE; VIRAL CLEARANCE; VIRUS GENOME; ANTIVIRAL RESISTANCE; CLASSIFICATION; DRUG EFFECTS; FEMALE; GENETICS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; PHYLOGENY; VIROLOGY;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CHINA; DRUG RESISTANCE, VIRAL; FEMALE; GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; PHYLOGENY;

EID: 84923210167     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.10.029     Document Type: Article

References (13)

1. World Health, Organization. Avian influenza A(H7N9) virus. Geneva: WHO; 2014, Available at: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/18_reportwebh7n9number_20140714.pdf?ua=1 (Accessed November 20 2014).
2. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, et al. Infectivity, transmission, and pathology of human H7N9 influenza in ferrets and pigs. Science 2013;341:183-6.
3. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013;368:1888-97.
4. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu HY, et al. Preliminary report: Epidemiology of the avian influenza A (H7N9) outbreak in China. N Engl J Med 2013. http://dx.doi.org/10.1056/NEJMoa1304617.
5. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28:2731-9.
6. Gubareva LV, Webster RG, Hayden FG. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res 2002;53:47-61.
7. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility-Geneva, November 2011 and June 2012. Wkly Epidemiol Rec 2012;87:369-74.
8. Jonges M, Welkers MR, Jeeninga RE, Meijer A, Schneeberger P, Fouchier RA, et al. Emergence of the virulence-associated PB2 E627K substitution in a fatal human case of highly pathogenic avian influenza virus A(H7N7) infection determined by illumina ultra-deep sequencing. J Virol 2013 Nov 20 [Epub ahead of print].
9. Zhang H, Li X, Guo J, Li L, Chang C, Li Y, et al. The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J Gen Virol 2014 Jan 6 [Epub ahead of print].
10. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 2013;347:f4752.
11. Wu Y, Bi Y, Vavricka CJ, Sun X, Zhang Y, Gao F, et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza virus. Cell Res 2013;23:1347-55.
12. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013;368:2277-85.
13. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and emergence of antiviral resistance. Lancet 2013;381:2273-9.